Page 29 - _NIPER-G Annual Report 2019-201

Department of Pharmaceutics
The major apparitions for the Department of Pharmaceutics are to inculcate how the me-too
active pharmaceutical ingredients can be converted into outcome-oriented as well as patient-
friendly end-user formulations.

Through the industrial-oriented syllabus contents and intense training at this department
during their study, the students are exposed to recent know-how of the technology used to
make the final formulations.

The basic knowledge about pharmaceutical technology and the proper way to get patent for
their innovative ideas are the additional unique features of the program blended with the
presence of highly-reputed faculty members with vast experience.

Major Thrust Area of the Department
 Dosage form design, development, optimization and evaluations for BCS-II & III drugs
 Micro-and nanotheragnosis concepts for the early detection and treatment of malignant
diseases and other life-threatening diseases
 Eradication of biofilm-producing microorganisms from the surfaces of implanted or
inserted medical devices into human body
 Ligand anchored lipid/polymer-mediated nanoarchitectonics
 Pharmacoengineering approaches to fight against neglected diseases
 Pharmaceutical Additive Manufacturiung Engineering / 3D-4D Printing Technology
 Nanomedicines for organ/lymphatic delivery with deep molecular insights
 Extrusion based biofilaments processing for fused-filaments applications
 Translational cutting-edge pharmaceutical research & development

26 NIPER-G